1. Drug Elimination Drug elimination consists of 2 processes
Drug Metabolism or Biotransformation
Drug Excretion

2. METABOLISM
Biotransformation, or drug metabolism, is the enzyme-catalyzed conversion of drugs to their metabolites.
Most drug biotransformation takes place in the liver.

3. Clinical sketch
A man with moderately severe alcoholic liver disease needs flecainide for a cardiac arrhythmia. The clinical team consults Appendix of the BNF and is advised to give reduced doses.
Comments： flecainide accumulates in patients with chronic liver disease.

4. WHY IS DRUG BIOTRANSFORMATION NECESSARY?
The majority of drugs are lipid-soluble to some extent.
Most lipid-soluble drugs filtered through the glomerulus are largely reabsorbed into the systemic circulation during passage though the renal tubules.
lipid-soluble drug
water-soluble drug

6. WHY IS DRUG BIOTRANSFORMATION NECESSARY?
The end result of metabolism is that the original drug molecule is altered in ways that make the drug more polar, hydrophilic, and water soluble
Without metabolism, 99.9% of all drugs filtered at the glomerulus would be reabsorbed into systemic circulation.

7. Role of Drug Biotransformation
The fundamental role of drug-metabolizing enzymes is to inactivate and detoxify drugs and other foreign compounds (xenobiotics).
Drug metabolites are usually more water soluble than is the parent molecule.

8. Role of Drug Biotransformation
No particular relationship exists between biotransformation and pharmacologic activity.
Most conjugated drug metabolites are inactive, but a few exceptions exist.

9. Formation of Active Metabolites
Some agents, known as prodrugs, are administered as inactive compounds and then biotransformed to active metabolites.

10. Paracetamol poisoning
Toxic metabolites of paracetamol are detoxified by phase II conjugation joining with glutathione.
In an overdose situation, toxic metabolites accumulate causing toxicity and can result in hepatitis.

11. Phases of Drug Biotransformation

12. General Metabolic Pathways
Phase I reactions – Functionalization
Oxidation
Reduction
Hydrolytic reactions
Purpose
Introduction of polar functional groups in a molecules
Hydroxyl groups; Carboxylate groups; Amino Groups; Thiol Groups
Increase a molecules polarity
Does provide a site for phase II metabolism

13. Phase I reactions
Oxidative Reactions
Oxidative reactions are catalyzed by enzymes isolated in the microsomal fraction of liver homogenates (the fraction derived from the endoplasmic reticulum) and by cytoplasmic enzymes.
Cytochrome P450s are the enzymes that catalyze phase I reactions.

14. Cytochrome P450 Monooxygenase System
A family of enzymes that catalyze the biotransformation of drugs
Modest specificity for substrates and catalyze the metabolism of widely differing chemical structures
Characterized by an intense absorption band at 450 nm in the presence of carbon monoxide.
Phase I reactions

15. family ≥40% subfamily≥55%

16. ROLE OF CYP ENZYMES IN HEPATIC DRUG METABOLISM
RELATIVE HEPATIC CONTENT OF CYP ENZYMES
% DRUGS METABOLIZED BY CYP ENZYMES

17. Genetic polymorphisms exist for these genes
Cytochrome P450
Monooxygenase System
Genetic polymorphisms exist for these genes
Genetic variations in these metabolism genes can have important consequences for patients.
“Poor metabolizers” have a greater risk than the general population of experiencing adverse drug reactions.

18. Hydrolysis of Esters and Amides
Catalyzed by widely distributed hydrolytic enzymes
Cholinesterase and other plasma esterases
Few CYP enzymes that carry out
hydrolytic reactions
Phase I reactions

19. Phase I reactions
Reductive Reactions
Less common than are oxidative and hydrolytic reactions.
Nitroglycerin, a vasodilator, undergoes reductive hydrolysis catalyzed by glutathione- organic nitrate reductase.

20. General Metabolic Pathways
Phase II reactions – Conjugation
Purpose
Introduce highly polar conjugates
Glucuronic acid; Sulfate; Glycine or other Amino Acids; Glutathione
Conjugation enzymes are present in the liver and other tissues
Conjugates are readily excreted in the urine
Usually inactive - notable exception is morphine 6-glucuronide

21. Enzyme Induction and Inhibition
Many drugs alter drug metabolism by inhibiting or inducing CYP enzymes.
Drug interactions can occur when these drugs are administered concurrently with other drugs that are metabolized by CYP.

22. Enzyme Induction
Enzyme induction is the process by which exposure to certain substrates results in accelerated biotransformation with a corresponding reduction in parent drug.
Enzyme inducer stimulates the synthesis of the enzyme and the metabolic capacity is increased

23. Consequences of Induction
Increased rate of metabolism
Decrease in drug plasma concentration
Enhanced oral first pass metabolism
Reduced bioavailability
If metabolite is active or reactive, increased drug effects or toxicity

24. Clinical sketch
A young woman on the contraceptive pills is found to have tuberculosis. She is started on treatment and suffers contraceptive failure soon after.
Comments： it would be unacceptable practice to fail to warn the woman that rifampicin (which induces the liver drug-metabolising enzyme CYP450) is very likely to cause failure of contraception.

25. Therapeutic Implications of Induction
Most drugs can exhibit decreased efficacy due to rapid metabolism
but drugs with active metabolites can display increased drug effect and/or toxicity due to enzyme induction
Dosing rates may need to be increased to maintain effective plasma concentrations

26. Induction
Auto-inducer
Some currently used drugs are well known to induce their own metabolism or the metabolism of other drugs.
The longer the drug is given, the more rapidly it is metabolized.

27. Enzyme Inhibition
Enzyme inhibitor inhibits the synthesis of the enzyme and the metabolic capacity is decreased
Cimetidine: CYP2C9 P450 enzyme inhibitor
Grapefruit +
Statins

28. Consequences of Inhibition
Increase in the plasma concentration of parent drug
Exaggerated and prolonged pharmacological effects
Increased likelihood of drug-induced toxicity

29. Enzyme induction will decrease the duration and intensity of the drug action.
The opposite is also true.
In cases where an enzyme is responsible for metabolizing a pro-drug into a drug, enzyme induction can speed up this conversion and increase drug levels, potentially causing toxicity.